Estudio comparativo, randomizado y de grupos paralelos con PET en pacientes esquizofrénicos de nuevo diagnóstico en tratamiento con Aripiprazol y Risperidona
- Conditions
- Schizophrenia
- Registration Number
- EUCTR2006-000980-26-ES
- Lead Sponsor
- Fundación para la Investigación biomedica del Hospital Gregorio Marañon
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with recent Schizophrenia diagnostic (less than 2 years) according DSM-IV-TR. Age: 18-30 years old
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Comorbility with Axe I DMS-IV. Pregnant and nursing women
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Quantification by standard uptake units value in brain areas for neuronal metabolic activity (glucose level);Secondary Objective: Treatment efficay and patient tolerability;Primary end point(s):
- Secondary Outcome Measures
Name Time Method